GN
Insider selling
Gilmore Neil O'Neill sold $16K of Editas Medicine, Inc. (EDIT) stock
Gilmore Neil O'Neill, CEO of Editas Medicine, Inc. (EDIT), sold 5,124 shares of EDIT stock worth $16K, per an SEC Form 4 filed Sep 4, 2026.
The sale was pre-arranged (a 10b5-1 plan or an option exercise), not a fresh decision.
The trade happened on Sep 3, 2026, 1 day before it was made public.
EDIT has moved -5.2% since the trade date, from $3.08 to $2.92 (Sep 22, 2026 close).
- Traded
- Sep 3, 2026
- Disclosed
- Sep 4, 2026
- Filing delay
- 1 day
- Price since
- -5.2%
- Role
- CEO
- Source
- SEC Form 4
More EDIT insider and Congress trades
From a public SEC Form 4, linked above. Not investment advice, and not a recommendation to buy or sell.